Eviscerate+ also contains sulfonated glucosamine which induces insulin resistance in tissues, including adipocytes
Invalid Link Removed
And the latest E+ release also has aminophylline, a PDE inhibitor and adenosine antagonist, further enhancing fat loss by reducing the breakdown of cAMP and antagonizing A1-adenosine receptor mediated inhibition of lipolysis.